Premium
A CASE OF METASTATIC YOLK SAC TUMOR OF TESTIS IN A CHILD
Author(s) -
Terai Akito,
Ishitoya Satoshi,
Hashimura Takayuki,
Takeuchi Hideo,
Yoshida Osamu
Publication year - 1995
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.1995.tb00443.x
Subject(s) - medicine , etoposide , bleomycin , yolk sac , retroperitoneal lymph node dissection , vinblastine , cisplatin , dissection (medical) , regimen , cyclophosphamide , chemotherapy , lymph node , endodermal sinus tumor , lymphadenectomy , testicular cancer , combination chemotherapy , lung , surgery , oncology , pathology , germ cell tumors , embryo , biology , microbiology and biotechnology
We report a case of testicular yolk sac tumor in a child aged 3 years and 6 months with multiple bulky metastases to lung and retroperitoneum (stage 11182). After three courses of chemotherapy with a PV 8 regimen (cisplatin, vinblastine and bleomycin). complete and partial responses were obtained for lung and retroperitoneal lymph node metastases, respectively. The patient was followed‐up closely. However, on the basis of a re‐elevated alpha‐letoprotein (AFP) after 4 months' follow‐up, he was treated with three courses of salvage chemotherapy with a modified VAB‐6 regimen (cyclophosphamide. etoposide. actinomycin D, bleomycin and cisplatin), lollowed by retroperitoneal lymph node dissection. Histologically, only necrotic tissue was found. There is no evidence of recurrence 24 months after lymphadenectomy. There is very little information in the literature on the appropriate management of postchemotherapy residual mass in pediatric testicular tumors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom